Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of a novel flow diverter, the DiVeRt system, in an animal model.
Hufnagl C, Broussalis E, Cognard C, Grimm J, Hecker C, Oellerer A, Abdallah M, Griessenauer CJ, Killer-Oberpfalzer M. Hufnagl C, et al. J Neurointerv Surg. 2022 Apr;14(4):384-389. doi: 10.1136/neurintsurg-2021-017430. Epub 2021 May 13. J Neurointerv Surg. 2022. PMID: 33986108
Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience.
Neureiter D, Mayr C, Winkelmann P, Neumayer B, Klieser E, Wagner A, Hufnagl C, Emmanuel K, Holzinger J, Koch O, Kiesslich T, Varga M. Neureiter D, et al. Among authors: hufnagl c. Cells. 2020 Feb 20;9(2):486. doi: 10.3390/cells9020486. Cells. 2020. PMID: 32093260 Free PMC article.
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.
Melchardt T, Weiss L, Hufnagl C, Neureiter D, Kemmerling R, Morre P, Boekstegers A, Hopfinger G, Auberger J, Steinkirchner S, Pleyer L, Greil R, Egle A. Melchardt T, et al. Among authors: hufnagl c. Leuk Lymphoma. 2015 Feb;56(2):353-60. doi: 10.3109/10428194.2014.916798. Epub 2014 Jun 25. Leuk Lymphoma. 2015. PMID: 24798743
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes T, Melchardt T, Hufnagl C, Weiss L, Mittermair C, Neureiter D, Klieser E, Rinnerthaler G, Roesch S, Gaggl A, Greil R, Egle A. Magnes T, et al. Among authors: hufnagl c. Pharmacogenomics J. 2018 May 22;18(3):474-479. doi: 10.1038/tpj.2017.37. Epub 2017 Jul 18. Pharmacogenomics J. 2018. PMID: 28719596
31 results